Novex Innovations is a full-service CDMO (Contract Development/Manufacturing Organization) providing support to clients in biological formulations, clinical formulation, tissue processing, bioengineered tissue, active pharmaceuticals, diagnostic materials, medical devices, and more. Operating since 2014, the company serves clients ranging from single-person operations to multinational corporations. Novex offers process development, manufacturing, storage, and product distribution under cGMP procedures and policies, maintaining cleanroom spaces at Class 1,000 and Class 100 levels for clinical and commercial manufacturing. Regulated under current ISO 13485 standards and FDA registration, Novex caters to national and international customers, providing storage options and shipping services on behalf of clients.
With an emphasis on biotechnology, Novex Innovations has positioned itself as a crucial partner for companies in the healthcare industry seeking to bring life-changing solutions to the market. Despite the absence of publicly available information regarding recent investments, Novex's strategic positioning and comprehensive service offerings present an exciting prospect for potential investors looking to tap into the CDMO sector within the United States.
There is no investment information
No recent news or press coverage available for Novex Innovations.